Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

Cognitive function in postmenopausal women receiving letrozole or tamoxifen as adjuvant endocrine treatment was compared during the fifth year of treatment in a substudy of the BIG 1-98 trial. In BIG 1-98 patients were randomized to receive adjuvant A) 5-years tamoxifen, B) 5-years letrozole, C) 2-y...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Phillips, Kelly Anne, Ribi, Karin, Sun, Zhuoxin, Stephens, Alisa, Thompson, Alastair, Harvey, Vernon, Thürlimann, Beat, Cardoso, Fatima, Pagani, Olivia, Coates, Alan S., Goldhirsch, Aron, Price, Karen N., Gelber, Richard D., Bernhard, Jürg
التنسيق: Artigo
اللغة:Inglês
منشور في: 2010
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2921449/
https://ncbi.nlm.nih.gov/pubmed/20385495
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2010.03.025
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة